GGrantIndex
Sort

40,608 grants matching prostate cancer

NRG Oncology Network Group Operations Center

$1,094,150
Norman Wolmark · Nrg Oncology Foundation, Inc. · U10 · FY2023 · CA

APT: the Analytical Proteomics Team

$1,093,652
Fred E Regnier · Purdue University · U24 · FY2009 · CA

Animal Model and Genotyping Core Support Facility

$1,093,069
Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA

Leveraging DNA damage repair pathways as therapeutic targets in womens cancers

$1,092,801
Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

FACTORS ASSOCIATED WITH RACIAL AND ETHNIC DISPARITY IN QUALITY OF PROSTATE CANCER CARE AMONG VETERANS AND NON-VETERANS

$1,092,628
Trustees Of The University Of Pennsylvania, The · · FY2019 · Defense Health Agency

3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership

$1,092,481
Upender Manne · University Of Alabama At Birmingham · U54 · FY2019 · CA

Targeted Discovery of Marine-derived Anticancer Leads

$1,092,108
Phil Crews · University Of California Santa Cruz · U19 · FY2008 · CA

CANTRANce: A tool to translate intermediate endpoints to mortality in CE studies

$1,091,952
Ruth D Etzioni · Fred Hutchinson Cancer Research Center · RC4 · FY2010 · CA

BIOMARKERS IN THE DETECTION OF PROSTATE CANCER IN AFRICAN AMERICANS

$1,091,864
University Of Alabama At Birmingham · · FY2010 · Department of Defense

CLINICAL QUALIFICATION OF DNA REPAIR DEFECTS AS BIOMARKERS IN METASTATIC PROSTATE CANCER USING INTEGRATED GENOMICS AND TISSUE-BASED FUNCTIONAL ASSAYS

$1,091,198
University Of Washington · · FY2018 · Defense Health Agency

Toxicology (IND-enabling) studies for a novel nerve imaging agent for prostate cancer

$1,090,970
Stephen B Kahl · Manzanita Pharmaceuticals, Inc. · R44 · FY2025 · CA

Translational Research of Finasteride and Selenium Prevention of Prostate Cancer

$1,090,824
Clement C Ip · Roswell Park Cancer Institute Corp · P01 · FY2010 · CA

Modeling to Improve Prostate Cancer Outcomes Across Diverse Populations

$1,090,797
Ruth D Etzioni · Fred Hutchinson Cancer Research Center · U01 · FY2015 · CA

Morehouse School of Medicine/Tuskegee University/UAB Comprehensive Cancer Center Partnership

$1,090,193
James W Lillard · Morehouse School Of Medicine · U54 · FY2018 · CA

High-throughput sequencing to identify novel melanoma susceptibility genes

$1,090,017
Chad Daniel Huff · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA

Clinical Nursing and Data Management Core

$1,089,901
William Marston Linehan · Division Of Basic Sciences - Nci · ZID · FY2014 · CA

Genomewide Association Study of Prostate Cancer

$1,089,761
John S Witte · University Of California, San Francisco · U01 · FY2008 · CA

A Novel Optical Spectral Imaging System for Rapid Imaging of Breast Tumor Margins

$1,089,691
Nimmi Ramanujam · Duke University · R01 · FY2012 · EB

LMPACT OF A MINORITY PROSTATE CANCER (MICAP) RESEARCH DIGEST IN TRANSLATING SCIENTIFIC DISCOVERY INTO PUBLIC HEALTH AND COMMUNITY APPLICATIONS

$1,089,679
University Of Florida · · FY2015 · Department of the Army

CONNEXINS AND CADHERIN CROSSTALK IN THE PATHOGENSIS OF PROSTATE CANCER

$1,089,676
Board Of Regents Of The University Of Nebraska · · FY2012 · Department of Defense

Center of Excellence for Cancer Research, Training and Community Service

$1,089,565
Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · P20 · FY2016 · MD

CHARACTERIZATION OF EARLY STAGE PROSTATE CANCER

$1,089,335
Sidney Kimmel Cancer Center · U01 · FY2000 · CA

CNTR OF EXCELLENCE FOR PROSTATE CANCER RESEARCH EDUCATION AND COMM SERVICE

$1,089,205
Shafiq A Khan · Clark Atlanta University · P20 · FY2015 · MD

CHEMOPREVENTION OF FAMILIAL PROSTATE CANCER

$1,088,877
University Of California Irvine · U19 · FY2003 · CA

National Capital Area (NCA) Minority/Underserved NCORP

$1,088,847
Lucile L Adams-Campbell · Georgetown University · UG1 · FY2020 · CA